Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Shire image

Shire signs CNS disorders deal with Heptares

March 23, 2012 Research and Development A2A, CNS, GPCR, Heptares, Shire

Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …
News

Early-stage research gains another funding boost

March 23, 2012 Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …
News
screen_shot_2012-03-22_at_11

Working Life: Mike Crooks, UK general manager, Astellas

March 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life

 Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …
Feature
GSK image

GSK selects Ulverston for biopharma manufacturing hub

March 22, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …
News

Former Roche man Guido Magni joins Versant

March 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm

Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …
Appointment
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012 Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
News

British biotech industry gains £200m boost

March 21, 2012 Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012 Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
News

UCB signs £3.6m research deal with Oxford University

March 20, 2012 Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
News
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012 Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …
News

AstraZeneca touting for business at partnering conference

March 19, 2012 Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …
News
Novartis HQ

Novartis signs experimental eye drug deal

March 19, 2012 Research and Development, Sales and Marketing Novartis, ThromboGenics, vitreomacular adhesion

Novartis will develop an experimental eye drug with ThromboGenics in a pact worth nearly $500 million.  The deal has been …
News
meeting image

Meetings, bloody meetings

March 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials

I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …
Feature

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

March 15, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …
News
Press release

Photodynamic treatment for HPV shows potential

March 15, 2012 Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026